Navigation Links
Kendle Announces Postponement of 2011 Annual Meeting
Date:5/6/2011

CINCINNATI, May 6, 2011 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company is postponing its Annual Meeting of Shareholders due to its merger agreement with INC Research, LLC.  The annual meeting had been scheduled for May 19, 2011, in Cincinnati, Ohio.  Kendle announced May 4, 2011, that it has signed a merger agreement with INC Research.  The merger transaction requires the approval of Kendle's shareholders.

The annual meeting was postponed to provide shareholders adequate information and time to review the proposed merger.  At a later date, Kendle's Board of Directors will establish a new record date and meeting date for the annual meeting and the Company will send a revised annual meeting notice and proxy statement to shareholders.

Kendle believes it is appropriate to avoid the unnecessary cost of holding both an annual meeting to address the five proposals included in the Proxy Statement sent April 15, 2011, and another special shareholders' meeting to approve the merger.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry.  Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide.  As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. INC Research to Acquire Kendle International for $15.25 per Share in Cash
2. Kendle Chairman and CEO Receives Lifetime Achievement Award at Cincinnati USA Innovation Awards
3. Kendle Executives to Share Insights at 20th Annual Partnerships in Clinical Trials Conference
4. Kendle Announces Fourth Quarter and Full-Year 2010 Results
5. Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
6. Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
7. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
8. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
9. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
10. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
11. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 2, 2014 Research and Markets  has ... Market - Industry Analysis, Size, Share, Growth, Trends and ... The home healthcare market involves wide ... to treat or diagnose a variety of chronic diseases. ... providing cost-effective health care to the patients. Home healthcare ...
(Date:10/2/2014)... , Oct. 2, 2014  Perrigo Company plc (NYSE: ... the laws of Ireland (the " ... exchange (the "Exchange Offer") up to $500,000,000 of its new ... "), $600,000,000 of its new 2.30% Senior Notes due 2018 ... 4.00% Senior Notes due 2023 (the " 2023 Exchange Notes ...
(Date:10/2/2014)... , Oct. 2, 2014   Mast Therapeutics, ... announced today that Edwin L. Parsley , D.O. ... and Senior Vice President.  Dr. Parsley has ... Aires Pharmaceuticals, Inc. in February 2014.  He has served ... and as Chief Medical Officer of Aires since April ...
Breaking Medicine Technology:Global Home Healthcare (Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies) Market - Trends and Forecast, 2014 - 2020 2Global Home Healthcare (Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies) Market - Trends and Forecast, 2014 - 2020 3Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Expiration Of Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023, 5.30% Senior Notes Due 2043 4Mast Therapeutics Announces Appointment Of Chief Medical Officer 2Mast Therapeutics Announces Appointment Of Chief Medical Officer 3Mast Therapeutics Announces Appointment Of Chief Medical Officer 4
... Novavax, Inc. (Nasdaq: NVAX ), a clinical-stage vaccine ... Novavax, will be presenting at the ROTH 23rd Annual OC ... local time at The Ritz Carlton, Laguna Niguel, CA.  A ... via the Company website at www.novavax.com under Investors/Events, ...
... Halozyme Therapeutics, Inc. (Nasdaq: HALO ), ... the extracellular matrix for the endocrinology, ... financial results for the fourth quarter and year ... http://photos.prnewswire.com/prnh/20100302/LA63139LOGO ) "I am energized and ...
Cached Medicine Technology:Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results 2Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results 3Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results 4Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results 5Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results 6
(Date:10/1/2014)... strongly associated with Alzheimer,s disease; however, researchers are still ... causal agent of the onset and development of the ... beta-amyloid is not harmful when found in isolation but ... to form the so-called amyloid fibrils , "We are ... with multiple ones because each aggregate of peptide, which ...
(Date:10/1/2014)... published today in the Journal of the American ... 50 years with moderate or severe chronic knee pain, ... the University of Melbourne randomly assigned 282 patients (50 ... acupuncture or sham or pretend laser treatment. , ... acupuncturists blinded to laser and sham (inactive) laser acupuncture. ...
(Date:10/1/2014)... Physical Sciences Research Council (EPSRC) will focus on ... systems which run, for example, manufacturing plants, power ... , The research will help understand and ... systems behind our critical national infrastructure. , ... (RITICS), based at Imperial College London, is co-ordinating ...
(Date:10/1/2014)... 2014) Despite a policy focus on expanding ... this vulnerable population continues to have significant dental ... Journal of the American Dental Association , researchers ... University School of Dental Medicine report on the ... oral care provided by caregivers to adults with ...
(Date:10/1/2014)... October 01, 2014 Familylifeinsurancequotes.org has ... life insurance for senior citizens. , Senior citizens ... will now sell coverage to seniors who are over ... be purchased without taking a medical examination. , Term ... online and senior clients can qualify. Having life insurance ...
Breaking Medicine News(10 mins):Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2
... common. Most people are down with at least two to ... could// help reduce the number of infections. , ,According ... after contact with an infected surface and not so much ... advice, that it is imperative to wash hands thoroughly and ...
... have uncovered the role played by a gene associated with the ... for its role in diabetes and obesity, explained Michel L. Tremblay, ... ,Their study, published in the magazine Nature Genetics, shows that ... slowed the growth of - and in some cases, prevented - ...
... in different Kerala jails will perform a three-hour programme before ... is for the first time in Kerala that prisoners are ... of Police G. Baburaj told reporters here Monday., ... besides that they also have a social urge and we ...
... with Parkinson’s disease in 15 of the world’s largest nations ... study were published in the January 30 issue of the ... facing countries with rapidly growing economies, particularly in Asia, many ... health threat. ,In recent years, a great deal ...
... disclosed that suppression of an enzyme called PTP1B stalls ... This study was conducted on laboratory mice which were ... of humans. ,This research headed by Michel ... Quebec delayed the advancement of a particular kind of ...
... that throws light on the extent of neurological ailments in ... reams of medical research, Deborah Hirtz, and colleagues from the ... the most common and treated neurological diseases in the country. ... from the last 15 years and indexed the diseases according ...
Cached Medicine News:Health News:Worldwide Parkinson's Cases To Double In Next 25 Years 2Health News:Worldwide Parkinson's Cases To Double In Next 25 Years 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: